Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The randomized controlled trial will compare efficacy and safety of dexmedetomidine to midazolam for sedation during endobronchial ultrasound
Benzodiazepines, opioids, and propofol are currently used alone or in combination for achieving sedation during endobronchial ultrasound and other bronchoscopic procedures. However, all these agents carry a risk of respiratory depression. Dexmedetomidine, a highly selective adrenergic alpha-2 agonist, has sedative and analgesic properties but does not cause respiratory depression. This study aims to compare efficacy and safety of dexmedetomidine as a sedative to midazolam in patients with hilar/mediastinal lymphadenopathy undergoing convex-probe endobronchial ultrasonography on day care basis. Patients will be randomized to receive either dexmedetomidine plus fentanyl or midazolam plus fentanyl prior to procedure, followed by dexmedetomidine or saline infusion respectively during the procedure. Ramsay sedation score of two will be targeted, failing which patients in both groups will receive midazolam bolus on as-needed basis. Bronchoscopist will remain blinded to group allocation. Patients will be monitored for sedation, oxygenation and hemodynamic parameters throughout. Need for additional midazolam, sedative efficacy, frequency of adverse respiratory and hemodynamic events, and bronchoscopist and patient satisfaction with the procedure will be compared between the two groups.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dexmedetomidine | Experimental | Dexmedetomidine + fentanyl before, and dexmedetomidine infusion during, procedure |
|
| Midazolam | Active Comparator | Midazolam + fentanyl before, and matching saline infusion during, procedure |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dexmedetomidine | Drug | Dexmedetomidine 1µg/Kg in 100 mL saline intravenously over 10-15 minutes immediately prior to procedure, followed by Dexmedetomidine infusion at 0.6 µg/kg/hour as maintenance dose during entire procedure |
| Measure | Description | Time Frame |
|---|---|---|
| Number of midazolam boluses administered to achieve targeted Ramsay sedation score of two | From start of endobronchial ultrasound procedure until finish of endobronchial ultrasound procedure, assessed up to two hours |
| Measure | Description | Time Frame |
|---|---|---|
| Mean difference in depth of sedation during procedure as assessed by Ramsay scale | From start of endobronchial ultrasound procedure until finish of endobronchial ultrasound procedure, assessed up to two hours | |
| Frequency of adverse hemodynamic events - hypotension, hypertension, tachycardia, bradycardia |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research | Chandigarh | Chandigarh | 160023 | India |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33849367 | Derived | Kumari R, Jain K, Agarwal R, Dhooria S, Sehgal IS, Aggarwal AN. Fixed dexmedetomidine infusion versus fixed-dose midazolam bolus as primary sedative for maintaining intra-procedural sedation during endobronchial ultrasound-guided transbronchial needle aspiration: a double blind randomized controlled trial. Expert Rev Respir Med. 2021 Dec;15(12):1597-1604. doi: 10.1080/17476348.2021.1918000. Epub 2021 Apr 25. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020927 | Dexmedetomidine |
| D005283 | Fentanyl |
| ID | Term |
|---|---|
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Midazolam bolus | Drug | Midazolam 2 mg as slow intravenous bolus immediately prior to procedure |
|
| Saline placebo | Other | 100 mL saline infusion over 10-15 minutes immediately prior to procedure |
|
| Rescue midazolam | Drug | Rescue boluses of 0.5 mg midazolam, if needed during procedure |
|
| Fentanyl | Drug | 1 µg/kg fentanyl as slow intravenous bolus immediately prior to procedure |
|
| From start of endobronchial ultrasound procedure until finish of endobronchial ultrasound procedure, assessed up to two hours |
| Frequency of respiratory events - hypoxia, need for air airway maneuvers to maintain oxygenation | From start of endobronchial ultrasound procedure until finish of endobronchial ultrasound procedure, assessed up to two hours |
| Mean difference in patient and physician satisfaction related to procedure as assessed by visual analogue scale | Immediately after endobronchial ultrasound procedure |
| Mean difference in time taken to discharge patient from post-procedure recovery room | From end of endobronchial ultrasound procedure until final patient discharge from recovery room, assessed up to twelve hours |
| D010880 |
| Piperidines |